Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AdipoUpX™ Human CIDEC Lentiviral Particle (Overexpression)
Cat. No.:
V1225XX493
Species:
Human
Target Gene:
CIDEC
Vector System:
Lentiviral
Modulation Type:
Overexpression
SPECIFIC INQUIRY
Add to basket
Product Overview
Description:
AdipoUpX™ Human CIDEC Lentiviral Particle (Overexpression) is professionally engineered for the efficient and long-lasting overexpression of the human CIDEC (Fsp27) gene. This protein is a master regulator of lipid droplet fusion and fat storage capacity; this stable integration system is an ideal tool for studying adipocyte hypertrophy. Every viral lot undergoes comprehensive quality control (titer, sterility, and mycoplasma detection) to ensure safety and efficacy. The product is ready-to-use, allowing researchers to rapidly validate CIDEC's effects on lipid accumulation.
Production Cell Line:
HEK293T
Promoter:
Ubi; CMV; EF1a; Others
Product Availability:
Produced Upon Order
Specification
Titer Test:
qPCR
Insert Verification:
PCR analysis was performed to verify the complete genomic sequence of all viral vector preparations.
Sterility Test:
This product was certified sterile following successful microbial growth analysis.
Mycoplasma Test:
The production quality control confirmed the absence of any mycoplasmal agents.
Other QC:
This comprehensive process includes customized supplementary testing alongside in vitro and in vivo transduction assessments to elucidate transgene expression and functionality.
Storage:
To maintain product integrity, immediate transfer of the vector to a -80 °C is essential following its receipt.
Stability:
Continuous storage at -80°C ensures excellent long-term stability for 6-12 months. Once thawed, the product's working solution should be refrigerated at 4°C and used within 2-3 weeks.
Shipping Condition:
Our lentivirus viral products are shipped using dry ice.
Handling Notes:
Ensure all operations are performed within a biosafety cabinet; upon receiving the vector, immediately aliquot it into low-protein-binding tubes and store according to specified conditions, thus avoiding the titer loss caused by sensitivity to temperature fluctuations and freeze-thaw cycles.
Intended Use:
This product is intended for research use only and is not for use in diagnosis or therapeutic applications.
Product Disclaimer:
Given the diversity and complexity of experimental conditions, we do not guarantee product performance or experimental results in any specific application, despite our company's commitment to product quality and the rigorous internal QC inspections all products have undergone. Ultimate responsibility remains with the user for all operational processes, including storage, handling, and compliance with safety and biosafety protocols.
Target Profile
Gene Name:
CIDEC
Full Name:
Cell death inducing DFFA like effector c
Gene Symbol:
CIDE3; FPLD5; FSP27; CIDE-3
Gene ID:
63924
RefSeq ID-1:
NP_001186480.1
RefSeq ID-2:
NM_001199551.2
Summary:
CIDEC is a specialized regulator of lipid storage that facilitates the expansion of lipid droplets within fat cells. Its expression is tightly coupled with insulin sensitivity; as insulin levels rise, CIDEC works to safely sequester fats. When this gene is mutated or poorly expressed, it can lead to fragmented lipid storage and lipodystrophy, ultimately contributing to insulin-resistant diabetes. It effectively balances adipocyte survival with efficient energy storage.